Delivery Order SPE2DX22D0010-SPE2D826FBA26
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,279.88 to AmerisourceBergen Drug Corp on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare procurement needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $105,287.65 to AmerisourceBergen Drug Corp on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare needs. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $451,562.58 to AmerisourceBergen Drug Corp on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $345,601.20 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contractor's corporate office, located in Conshohocken, Pennsylvania, will serve as the place of performance....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $129,844.04 to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,958.54 to AmerisourceBergen Drug Corp on August 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,569.06 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical and healthcare solutions provider. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $151,201.44 to AmerisourceBergen Drug Corp on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies required by federal healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp on August 28, 2025, with completion expected by August 29, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's larger indefinite delivery contract (IDC) vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a leading pharmaceutical distributor and healthcare...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBA26Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $116,005.04 to AmerisourceBergen Drug Corp on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and represents a continuation of the company's pharmaceutical distribution services to federal military and healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and will perform this delivery order at its Conshohocken, PA location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally. The DLA Troop Support is developing next-generation Pharmaceutical Prime Vendor Global Program contracts with plans for multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $116.0k | 11/12/25 |